ORS Chapter 475a — Psilocybin Regulation

ORS 475a.225. Members of Oregon Psilocybin Advisory Board; terms; meetings; compensation; rules. (1)(a) The Oregon Psilocybin Advisory Board is established within the Oregon Health Authority for the purpose of advising and making recommendations to the authority. The Oregon Psilocybin Advisory Board shall consist of: (A) 14 to 16 members appointed by the Governor as specified in paragraph (b) of this subsection; (B) The Public Health Director or the Public Health Directors designee; (C) If the Public Health Director is not the State Health Officer, the State Health Officer or a physician licensed under ORS chapter 677 acting as the State Health Officers designee; (D) If the Public Health Director is the State Health Officer, a representative from the Oregon Health Authority who is familiar with public health programs and public health activities in this state; and (E) A designee of the Oregon Health Policy Board. (b) The Governor shall appoint the following individuals to the board: (A) Any four of the following: (i) A state employee who has technical expertise in the field of public health; (ii) A local health officer, as defined in ORS 431.003; (iii) An individual who is a member of, or who represents, a federally recognized Indian tribe in this state; (iv) An individual who is a member of, or who represents, the Addictions and Mental Health Planning and Advisory Council within the authority; (v) An individual who is a member of, or who represents, the Health Equity Policy Committee within the authority; (vi) An individual who is a member of, or who represents, the Palliative Care and Quality of Life Interdisciplinary Advisory Council within the authority; and (vii) An individual who represents individuals who provide public health services directly to the public; (B) A psychologist licensed under ORS chapter 675 who has professional experience engaging in the diagnosis or treatment of a mental, emotional, or behavioral condition; (C) A physician licensed under ORS chapter 677 who holds a degree of Doctor of Medicine; (D) A naturopathic physician licensed under ORS chapter 685; (E) An expert in the field of public health who has a background in academia; (F) Any three of the following: (i) A person who has professional experience conducting scientific research regarding the use of psychedelic compounds in clinical therapy; (ii) A person who has experience in the field of mycology; (iii) A person who has experience in the field of ethnobotany; (iv) A person who has experience in the field of psychopharmacology; and (v) A person who has experience in the field of psilocybin harm reduction; (G) A person representing the Oregon Liquor and Cannabis Commission who has experience working with the system developed and maintained by the commission under ORS 475C.177 for tracking the transfer of marijuana items; (H) A person representing the Department of Justice; and (I) The following: (i) During the two-year program development period: (I) One of the chief petitioners of chapter 1, Oregon Laws 2021; and (II) One or two at-large members; and (ii) After the two-year program development period, one, two, or three at-large members. (2)(a) The term of office for a board member appointed under this section is four years, but a member serves at the pleasure of the Governor. Before the expiration of the term of a member, the Governor shall appoint a successor whose term begins on January 1 next following. A member is eligible for reappointment. If there is a vacancy for any cause, the Governor shall make an appointment to become immediately effective for the unexpired term. (b) Members of the board described in subsection (1)(a)(B) to (E) of this section are nonvoting ex officio members of the board. (3) A majority of the voting members of the board constitutes a quorum for the transaction of business. (4) Official action by the board requires the approval of a majority of the voting members of the board. (5) The board shall elect one of its voting members to serve as chairperson. (6) During the two-year program development period, the board shall meet at least once every two calendar months at a time and place determined by the chairperson or a majority of the voting members of the board. After the two-year program development period, the board shall meet at least once every calendar quarter at a time and place determined by the chairperson or a majority of the voting members of the board. The board also may meet at other times and places specified by the call of the chairperson or of a majority of the voting members of the board. (7) The board may adopt rules necessary for the operation of the board. (8) The board may establish committees and subcommittees necessary for the operation of the board. (9) Members of the board are entitled to compensation and expenses as provided in ORS 292.495. [2021 c.1 6] Note: As originally enacted by the people, the leadline to ORS 475A.225 read Members; terms; meetings; compensation. The leadline was changed by editorial action. Note: Legislative Counsel has substituted chapter 1, Oregon Laws 2021, for the words this 2020 Act in section 6, chapter 1, Oregon Laws 2021, compiled as 475A.225. Specific ORS references have not been substituted, pursuant to 173.160. The sections for which substitution otherwise would be made may be determined by referring to the 2021 Comparative Section Table located in Volume 22 of ORS.